Acceptability of HPV-self Sampling

Evaluation of the Acceptability of HPV Self-sampling Among French Women Eligible for Cervical Cancer Screening

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03137563

Enrollment

356

Registered

2017-05-02

Start date

2017-05-15

Completion date

2019-07-30

Last updated

2020-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cervical Cancer

Keywords

Women, 25-65 years

Brief summary

This trial aimed at evaluating the acceptability of HPV self-sampling among french women eligible for cervical cancer screening (25 - 65 years old) in the region of Occitanie, in the south of France. Acceptability will be evaluated using an anonymous questionnaire and the main outcome of the study will be the response acceptability yes or no for HPV self-sampling. Secondary outcome will be analysis of socioeconomic determinants for the acceptability of HPV self-sampling. These data will help to propose new strategies for cervical cancer screening in France, particularly to taget non-attenting populations

Detailed description

Women will be recruted in 8 centers located in 2 departments , Aude and Herault (in the Region of Occitanie in the south of France).The questionnaire will be proposed to the women attending one of these eight centers by an investigator, who will verify the inclusion and exclusion criteria. The same person will collect the filled questionnaire. The questionnaire is anonymous and is composed of 15 questions evaluating the acceptability of HPV self-sampling and socio-economic determinants. These questionnaires will be collected and statistical analysis will be performed using appropriate tools. This study will bring informations on the acceptibility of HPV self sampling among french women eligible for cervical cancer screening in 2 Departements of the South of France. Self-sampling acceptability will be linked to socio-economic determinants. These data will be important to propose and evaluate new strategies to improve screening coverage, particularly of the context of the organized cervical cancer screening that will take place in France in 2018.

Interventions

OTHERquestionnaire

The questionnaire will be distributed and collected by the same investigator in one of the eight centers involved in the study. The investigator will verify the inclusion criteria and the absence of exclusion criteria.

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

FEMALE

Age

25 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Women 25-65 years old * Living in the Aude or Herault departments * Informed patient

Exclusion criteria

* Virgins * Previous hysterectomy * Present or previous cervical pathology * Patient under guardianship or tutorship

Design outcomes

Primary

Measure	Time frame	Description
accept HPV self-sampling for cervical cancer	1 day	Response Yes or No to the question would you accept HPV self-sampling for cervical cancer screening ?

Secondary

Measure	Time frame	Description
Socioeconomic determinants of the response	1 day	Socioeconomic determinants of the response yes or no to the question would you accept HPV self-sampling for cervical cancer screening ?

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026